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SHORT REPORT Open Access
The value of the infection prevention and
control nurse led MRSA ward round
Mark I. Garvey1,2* , Craig W. Bradley3, Martyn A. C. Wilkinson1, Kerry L. Holden3, Victoria Clewer1 and
Elisabeth Holden1
Abstract
Meticillin-resistant S. aureus (MRSA) is prevalent in most parts of the world. The study took place at Queen Elizabeth
Hospital Birmingham (QEHB) a UK tertiary referral hospital. At QEHB innovative nurse led daily ward rounds for
patients that acquire hospital acquired MRSA during their hospital stay are undertaken. The aim is to optimise care
delivered for these patients whilst at QEHB, thereby reducing the risk of infection in patients with healthcare-
acquired MRSA. A segmented Poisson regression model suggests that the MRSA bacteraemia rate was affected
where an 88.94% reduction (p = 0.0561) in bacteraemias was seen by the introduction of these ward rounds. We
describe a nurse led MRSA ward round which was associated with a lower rate of MRSA bacteraemias.
Keywords: MRSA bacteraemia’s, MRSA, Infection control nurse led ward rounds
Background
Staphylococcus aureus is a major cause of healthcare-as-
sociated infection worldwide [1–3]. Meticillin-resistant
S. aureus (MRSA) has become prevalent in most parts
of the world [1–3]. Despite its decline in incidence in
several European countries, MRSA infection remains a
major cause of avoidable morbidity and mortality in
patients admitted to hospital [1–3]. It results in in-
creased length of hospital stay, risk of death and treat-
ment costs, with colonised and infected patients acting
as reservoirs for the spread of MRSA within hospitals
[1–3]. Isolation and decolonisation are the two main tar-
geted control measures for reducing transmission [2, 3].
Bradley et al., (2017) previously reported the effect of
universal MRSA decolonisation therapy in Intensive
Care Unit (ICU) patients regardless of patients’ MRSA
status [2]. A breakpoint model was used to identify an
increase in MRSA bacteraemias and acquisitions across
QEHB after the withdrawal of universal decolonisation
[2]. As a result, universal decolonisation was reintro-
duced into the ICU resulting in a reduction of MRSA
bacteraemias and acquisitions across QEHB [2]. Garvey
et al., (2018) followed on from this work and used a
Poisson model to demonstrate that the average hospital
acquisition rate of MRSA/100,000 patient bed days re-
duced by 6.3% per month after the introduction of a
new universal wipe regime [3]. Here, we follow on from
both these MRSA reduction strategies, by detailing the
effect of introducing a nurse-led ward round of patients
with healthcare associated MRSA while inpatients at
QEHB. Over the past 2 years all the MRSA bacteraemias
apportioned to QEHB were from patients whom ac-
quired hospital acquired MRSA while inpatients. As a
response to this QEHB introduced a nurse-led ward
round specifically focusing on this patient cohort.
Methods and materials
Setting
QEHB, part of University Hospitals Birmingham (UHB)
NHS Foundation Trust is a tertiary referral teaching
hospital in Birmingham, UK that provides clinical
services to nearly one million patients every year [2, 3].
MRSA screening
MRSA screening of all emergency and elective surgical
patients admitted to UHB is standard practice. Swabs
are taken from the nose, groin and throat as well as any
wounds or sites of invasive devices. Inpatients with
greater than 28 days’ stay are rescreened every 4 weeks.
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MRSA screens and clinical specimens were cultured as
described previously on Chromagenic agar [1–3].
MRSA acquisitions
At QEHB, a patient is defined as acquiring MRSA if they
have a negative admission screen and then have MRSA
isolated from a subsequent screen or clinical specimen,
48 h or more after admission. Only MRSA acquisitions
at QEHB were included in the analysis [2, 3].
MRSA bacteraemias
All MRSA bacteraemias were attributed as healthcare
associated or non-healthcare associated using the criteria
of the Centres for Disease Control and Prevention/Na-
tional Healthcare Safety Network for national reporting
purposes [4]. Only bacteraemias that were assigned to
QEHB were included in the analysis [2, 3].
Holistic nurse led MRSA ward round
From January 2017 onwards, QEHB commenced an in-
novative Infection Prevention and Control nurse (IPCN)
led daily MRSA ward rounds on patients that acquire
hospital acquired MRSA during their hospital stay. The
aim was to optimise care delivered for these patients
whilst in hospital, thereby reducing their risk of develop-
ing infection. Patients are assessed by IPCNs daily for
clinical features of infection. For example raised inflam-
matory markers such as C-reactive protein and white cell
count, signs of sepsis including increase in temperature,
change in blood pressure and respiratory rate, other signs
of infection including purulent wounds or erythema to
name but a few. There were no general criteria just clinical
judgement looking whether a patient had an infection or
not. Patients are seen at the bedside and physiological
parameters and laboratory markers are reviewed. When
signs of infection are present, these cases are escalated to
medical staff. In addition, patients are assessed for the
presence of invasive devices, for example urinary cathe-
ters, peripheral or central venous catheters and dialysis
catheters, as well as for the presence of invasive ventila-
tion. All devices are reviewed based on national guidance
and removed if no longer required [5]. Wound and skin
assessments are undertaken to identify breaks in the skin
and/or the presence of skin conditions. Patients’ decolon-
isation therapy is checked to ensure compliance with
QEHB’s policy for decolonisation and correct application
technique [2]. The ward rounds include confirmation that
appropriate Infection Prevention and Control precautions
are in place, including isolation, hand hygiene compliance
and the correct use of personal protective equipment such
as gloves and aprons. The antimicrobial prescriptions of
these patients are also reviewed to ensure there is appro-
priate MRSA cover if bacterial infection is suspected, with
any concerns/queries being escalated to clinicians and the
clinical microbiology service.
Statistical analysis
Segmented Poisson regression models containing offsets
for patient bed days were used to detect any significant
changes in the rate of MRSA acquisitions and bacterae-
mias from May 2016 – November 2018. This date range
was chosen to specifically analyse the effect of the
MRSA ward round which was implemented in January
2017 [2, 3]. ‘Full’ models were constructed containing
terms for changes in level and gradient associated with
the following potentially-important intervention: the im-
plementation of holistic MRSA acquisition ward rounds.
Backward step-wise regression was performed on the
‘full’ Poisson models, with the Akaike Information
Criterion used to select the models that best fit the data,
whilst guarding against over-fitting. All statistical ana-
lyses were performed using R version 3.4.3 [6, 7].
Audits
Regular audits were undertaken by the Infection Preven-
tion and Control Team during the period of this report.
Audits included monitoring hand hygiene compliance;
monitoring the appropriate use of personal protective
equipment and monitoring environmental cleanliness.
Results
MRSA acquisitions and bacteraemias
The optimum segmented Poisson models selected con-
tained terms for a change in the level of acquisitions and
bacteraemias, but no trend terms; the models suggest
that the number of MRSA acquisitions and bacteraemias
were immediately affected by the introduction of the
MRSA acquisition nurse led ward round (Fig. 1a and b).
The model shows, for MRSA acquisitions, there was a
reduction in mean from 14.50 per 100,000 bed days
between May 2016–December 2016, to 9.32 per
100,000 bed days between January 2017–November
2018 (Fig. 1a). This was a 35.7% reduction (p = 0.008,
95% confidence interval = (10.71, 53.70%)). The model
also demonstrates for MRSA bacteraemias, there was a re-
duction in mean from 0.805 per 100,000 bed days between
May 2016 – December 2016, to 0.089 per 100,000 bed
days between January 2017 – November 2018 (Fig. 1b).
This was an 88.94% reduction (p = 0.0561, 95% confidence
interval = (− 6.38, 98.85%)).
Auditing
Audits revealed no significant changes in hand hygiene
compliance; appropriate use of personal protective
equipment or environmental cleanliness during these pe-
riods (data not shown). MRSA screening for emergency
and elective patients averages never changed throughout
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the study periods. At UHB there is electronic prescribing
so all patients whom are MRSA positive receive
decolonization therapy.
Discussion
Between May 2016 to November 2018, all MRSA bacter-
aemias apportioned to QEHB were in patients who had
acquired MRSA as an inpatient. At QEHB, patients who
acquire MRSA while in hospital were therefore identified
to be at highest risk of developing MRSA bacteraemias.
This is not unexpected, since Torok et al., (2014) previ-
ously detailed in their hepatology population, higher
MRSA acquisition rate is often associated with higher
MRSA bacteraemias [8]. Roghmann et al., 2001 also
demonstrated a statistically significant high-risk ratio in
patients with MRSA bacteraemias when there was MRSA
colonisation of their chronic wounds [9]. There are
numerous reports in the literature describing MRSA ac-
quisition and the heightened risk of MRSA bacteraemias,
as seen in the QEHB bacteraemia patient group [8, 9].
Fig. 1 Using a segmented Poisson regression model changes in hospital wide monthly MRSA acquisition (a) and bacteraemia rates (b) per
100,000 bed days between May 2016–November 2018. Key: The dotted lines represent the infection prevention and control interventions. The
blue lines represent the mean values predicted by the Poisson regression model
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Due to the fact that patients acquiring MRSA at
QEHB are at greatest risk of developing an MRSA
bacteraemia, QEHB introduced a daily IPCN nurse led
ward round specifically focusing on this patient cohort.
A segmented Poisson regression model suggests that the
rate of MRSA acquisitions and bacteraemias have dimin-
ished since introduction of the MRSA acquisition ward
rounds. Overall, there is good evidence that the intro-
duction of a holistic nurse led ward MRSA acquisition
round was associated with a reduction in trust appor-
tioned acquisitions of MRSA, as well as some weaker
evidence of a concomitant decrease in bacteraemias.
Whilst the p-value of 0.0561 associated with the reduc-
tion in bacteraemias falls a little short of the value
usually regarded as formally significant, we feel that the
decrease is important, and that further data will under-
line its significance. Traditional power calculations
predict that the difference in the mean bacteraemias of
0.716, which comprises a nearly 90% reduction, would
be detected with a power of approximately 85% when
the level of significance is set at 5%. However, these cal-
culations assume heterogeneity of variance, which is
clearly not the case with MRSA bacteraemias; such
events are much rarer after the introduction of the ward
rounds. There is a wealth of literature describing suc-
cessful interventions from nurse led wards rounds. Brink
et al., (2016) discussed the role of pharmacists and
nurses in the reduction of antimicrobial consumption
[10]. Catangui et al., (2012) previously described the
benefits of a nurse led ward round in acute stroke care
[11]. Bradley et al., (2018) saw lower rates of recurrent
Clostridium difficile infection and reduced length of stay
as a result of specialist IPCN led C. difficile ward rounds
[11]. IPCN led ward rounds on various nosocomial
infections and clinical syndromes have the potential to
impact on the basics of patient care for the better.
It is important to note that there are confounders to
this observation that nurse led ward rounds have re-
sulted in a reduction in the number of MRSA bacterae-
mias seen at QEHB. Firstly, as per Bradley et al., (2017),
universal decolonisation of ICU patients has resulted
primarily in a reduction in the number of MRSA bacter-
aemias, so this could affect the results seen in this report
[2]. Secondly, as a result of the alteration in cleaning as
per Garvey et al., (2018), the change in practice at QEHB
from a two wipe system, to a universal one wipe clean-
ing regime has resulted in a reduction of the number of
MRSA acquisitions across QEHB [3]. This observation
will have an effect on the results seen in this report, as
the number of MRSA acquisitions have decreased,
thereby there are less patients acquiring MRSA to go on
to develop an MRSA bacteraemia. It is of note that the
acquisitions seem to have decreased after the introduc-
tion of the ward rounds. It could be that these rounds
have reduced transmission between MRSA positive
patients and the general hospital population, maybe by
decreasing environmental shedding.
Conclusions
Here, we describe some novel interventions in our local
management of MRSA, which have accounted for a
lower rate of MRSA bacteraemias. We suggest nurse led
MRSA acquisition ward rounds should be undertaken in
clinical practice to prevent MRSA acquisitions progres-
sing to MSRA bacteraemias. These successful nurse led
MRSA ward rounds could be adapted and utilised for
other nosocomial alert organisms such as multi-drug
resistant organisms, with the potential to observe better
patient outcomes.
Abbreviations
ICU: Intensive care unit; IPCN: Infection Prevention and Control Nurse;
MRSA: Meticillin-resistant S. aureus; QEHB: Queen Elizabeth Hospitals
Birmingham; UHB: University Hospitals Birmingham
Acknowledgements
We would like to thank the Infection Prevention and Control Team at QEHB
for their help in managing patients with MRSA acquisitions and generation
of the data in this paper.
Funding
None.
Availability of data and materials
Not applicable.
Authors’ contributions
All authors have contributed to the manuscript. Martyn Wilkinson has
analysed all the data. The lead author Mark Garvey has written and prepared
the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth
Hospital Birmingham, Edgbaston, Birmingham B15 2WB, UK. 2Institute of
Microbiology and Infection, The University of Birmingham, Edgbaston,
Birmingham, UK. 3Gloucestershire Hospitals NHS Foundation Trust,
Gloucestershire Royal Hospital, Gloucester GL1 3NN, UK.
Received: 23 December 2018 Accepted: 4 March 2019
References
1. Garvey MI, Winfield J, Wiley C, Reid M, Cooper M. Reduction in methicillin-
resistant Staphylococcus aureus colonisation: impact of a screening and
decolonisation programme. J Infect Prev. 2016;17(6):294–7.
Garvey et al. Antimicrobial Resistance and Infection Control            (2019) 8:53 Page 4 of 5
2. Bradley CW, Wilkinson MAC, Garvey MI. The effect of universal
decolonisation with screening in critical care to reduce MRSA across an
entire hospital. Infect Control Hosp Epidemiol. 2017;38(4):430–5.
3. Garvey MI, Wilkinson MAC, Bradley CW, Holden KL, Holden E. Wiping out
MRSA: effect of introducing a universal disinfection wipe in a large UK
teaching hospital. Antimicrob Resist Infect Control. 2018;19(7):155.
https://doi.org/10.1186/s13756-018-0445-7.
4. Guidance on the reporting and monitoring arrangements and post
infection review process for MRSA bloodstream infections from April 2014.
Patient Safety Domain, NHS England Available at: https://www.england.nhs.uk/
patientsafety/wp-content/uploads/sites/32/2014/02/post-inf-guidance2.pdf.
5. Torok ME, Harris SR, Cartwright JP, et al. Zero tolerance for healthcare-
associated MRSA bacteraemia: is it realistic? J Antimicrob Chemother.
2014;69:2238–45.
6. Roughmann MC, Siddiqui A, Plaisance K, Standiford H. MRSA colonization
and the risk of MRSA bacteremia in hospitalized patients with chronic
ulcers. J Hosp Infect. 2001;47:98–103.
7. Gebski V, Ellingson K, Edwards J, Jernigan J, Kleinbaum D. Modelling
interrupted time series to evaluate prevention and control of infection in
healthcare. Epidemiol Infect. 2012;140:2131–41.
8. R version 3.4.3 (2017-11-30) – “Kite-Eating Tree”. The R Foundation for
Statistical Computing.
9. Brink A, Van den Bergh D, Mendelson M, Richards GA. Passing the baton to
pharmacists and nurses: new models of antimicrobial stewardship for South
Africa? S Afr Med J. 2016;106(10):947–8.
10. Catangui EJ, Slark J. Nurse led ward rounds: a valuable contribution to acute
stroke care. Br J Nurs. 2012;21(13):801–5.
11. Bradley CW, Burdett H, Holden KL, Holden E, Garvey MI. How do we define
recurrence in Clostridium difficile infection? J Hosp Infect. 2018.
https://doi.org/10.1016/j.jhin.2018.07.026.
Garvey et al. Antimicrobial Resistance and Infection Control            (2019) 8:53 Page 5 of 5
